Literature DB >> 22008201

Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009.

C C Wielders1, R S van Binnendijk, B E Snijders, G A Tipples, J Cremer, E Fanoy, S Dolman, W l Ruijs, H J Boot, H E de Melker, S J Hahne.   

Abstract

We assessed the epidemiological characteristics of a mumps virus epidemic (genotype D) that occurred in the Netherlands between August 2007 and May 2009 and its association with a subsequent mumps outbreak in Canada. In the Netherlands, five data sources were used: notifications (only mandatory since the end of 2008) (56 cases), laboratory confirmation data (177 cases), a sentinel general practitioner (GP) database (275 cases), hospitalisation data (29 cases) and weekly virological reports (96 cases). The median age of cases in the notification, laboratory and GP databases ranged from 13 to 15 years. The proportion of cases that were unvaccinated ranged from 65% to 85% in the notification, laboratory and GP databases. Having orthodox Protestant beliefs was the main reason for not being vaccinated. In Canada, a mumps virus strain indistinguishable from the Dutch epidemic strain was detected between February and October 2008 in an orthodox Protestant community with historical and family links to the affected community in the Netherlands, suggesting that spread to Canada had occurred. Prevention and control of vaccine-preventable diseases among population subgroups with low vaccination coverage remains a priority.

Entities:  

Mesh:

Year:  2011        PMID: 22008201

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  19 in total

Review 1.  The rise (and fall?) of parental vaccine hesitancy.

Authors:  Charitha Gowda; Amanda F Dempsey
Journal:  Hum Vaccin Immunother       Date:  2013-06-06       Impact factor: 3.452

2.  A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax).

Authors:  Noni E MacDonald; Eve Dubé
Journal:  Can Commun Dis Rep       Date:  2020-01-02

3.  Outbreak of measles in an unvaccinated population, British Columbia, 2014.

Authors:  M Naus; D Puddicombe; M Murti; C Fung; R Stam; S Loadman; M Krajden; P Tang; M Lem
Journal:  Can Commun Dis Rep       Date:  2015-07-02

4.  Measles surveillance in Canada: Trends for 2014.

Authors:  L Sherrard; J Hiebert; S Squires
Journal:  Can Commun Dis Rep       Date:  2015-07-02

5.  How orthodox protestant parents decide on the vaccination of their children: a qualitative study.

Authors:  Wilhelmina L M Ruijs; Jeannine L A Hautvast; Giovanna van Ijzendoorn; Wilke J C van Ansem; Koos van der Velden; Marlies E J L Hulscher
Journal:  BMC Public Health       Date:  2012-06-06       Impact factor: 3.295

6.  Estimation of vaccine efficacy and critical vaccination coverage in partially observed outbreaks.

Authors:  Michiel van Boven; Wilhelmina L M Ruijs; Jacco Wallinga; Philip D O'Neill; Susan Hahné
Journal:  PLoS Comput Biol       Date:  2013-05-02       Impact factor: 4.475

7.  Mumps vaccine effectiveness against orchitis.

Authors:  Susan Hahné; Jane Whelan; Rob van Binnendijk; Corien Swaan; Ewout Fanoy; Hein Boot; Hester de Melker
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

8.  How healthcare professionals respond to parents with religious objections to vaccination: a qualitative study.

Authors:  Wilhelmina L M Ruijs; Jeannine L A Hautvast; Giovanna van IJzendoorn; Wilke J C van Ansem; Glyn Elwyn; Koos van der Velden; Marlies E J L Hulscher
Journal:  BMC Health Serv Res       Date:  2012-08-01       Impact factor: 2.655

9.  The role of religious leaders in promoting acceptance of vaccination within a minority group: a qualitative study.

Authors:  Wilhelmina L M Ruijs; Jeannine L A Hautvast; Said Kerrar; Koos van der Velden; Marlies E J L Hulscher
Journal:  BMC Public Health       Date:  2013-05-28       Impact factor: 3.295

10.  Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks.

Authors:  Gaby Smits; Liesbeth Mollema; Susan Hahné; Hester de Melker; Irina Tcherniaeva; Sandra Waaijenborg; Rob van Binnendijk; Fiona van der Klis; Guy Berbers
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.